RNU6-863P

Across TCGA pan-cancer cohorts, RNU6-863P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-863P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-863P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-863P expression acts as an unfavorable survival marker, although some lineages such as HNSC and BRCA show a favorable association.

STAD, KIRC, and HNSC are the cancer types where RNU6-863P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Median	III,IV	0.157	0.462	<.001	81	view →
KIRC	DFS	Tertile	IV	0.077	0.651	<.001	60	view →
HNSC	DFS	Tertile	IV	0.801	0.184	.016	33	view →
READ	DFS	Tertile	IV	0.183	0.639	.002	30	view →
BRCA	OS	Tertile	All	0.981	0.956	.004	20	view →
THCA	OS	Tertile	II,III,IV	0.648	0.838	.022	18	view →
ESCA	OS	Quartile	III,IV	0.561	0.302	.017	17	view →
OV	OS	Tertile	IV	0.612	0.799	.021	10	view →
LUSC	OS	Tertile	All	0.292	0.436	.011	10	view →
SKCM	DFS	Tertile	IV	0.943	0.159	.031	9	view →
LIHC	OS	Tertile	III,IV	0.850	0.596	.022	9	view →
ACC	DFS	Tertile	All	0.290	0.649	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-863P–STAD (DFS)

Open the STAD breakdown →